FCGR, Cetuximab, and Colorectal Cancer Survival-Letter

Clin Cancer Res. 2016 Oct 1;22(19):4958. doi: 10.1158/1078-0432.CCR-16-1470.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized
  • Cetuximab*
  • Colorectal Neoplasms*
  • Humans

Substances

  • Antibodies, Monoclonal, Humanized
  • Cetuximab